Novo Nordisk Agrees To Sell ZymoGenetics Stake For DKK1.1 Billion

Date : 09/08/2010 @ 2:00AM
Source : Dow Jones News
Stock : Zymogenetics (MM) (ZGEN)
Quote : 9.76  0.0 (0.00%) @ 2:05AM

Novo Nordisk Agrees To Sell ZymoGenetics Stake For DKK1.1 Billion

Novo Nordisk A S (NYSE:NVO)
Historical Stock Chart

5 Years : From Apr 2012 to Apr 2017

Click Here for more Novo Nordisk A S Charts.

Danish pharmaceutical company Novo Nordisk A/S (NVO) said Wednesday it will receive 1.1 billion Danish kroner ($187.7 million) after agreeing to sell its 26% stake in biopharmaceutical firm ZymoGenetics Inc. (ZGEN) to Bristol-Myers Squibb Co. (BMY).

Bristol-Myers Squibb overnight offered $9.75 per share in cash for each share in ZymoGenetics in a move that has been approved by the boards of both companies.

"As a significant shareholder with a long-term financial investment in ZymoGenetics, we find the offer from Bristol-Myers Squibb attractive and have entered into an agreement with Bristol-Myers Squibb to support the transaction and tender all of our ZymoGenetics shares in the offer," said Jesper Brandgaard, Novo Nordisk's executive vice president and chief financial officer.

Income from the transaction is exempt from tax charges under Danish law and the company expects it to have a positive effect on the group tax rate of 1.5 percentage points.

-By Dominic Chopping, Dow Jones Newswires; +46-8-5451-3093; dominic.chopping@dowjones.com

 
 



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.